Quoin’s ‘NETHERTON NOW’ campaign surpasses 1M video views

Quoin Pharmaceuticals (QNRX) announced that its NETHERTON NOW awareness campaign has surpassed a major milestone, achieving more than one million video views and over 14 million impressions. Launched to give patients, families, and experts a greater voice, NETHERTON NOW has become a global platform shining a spotlight on the painful realities of Netherton Syndrome, a rare and devastating genetic skin disease. The campaign’s videos, which highlight personal stories and clinical perspectives, have been widely circulated on social media with placement on major outlets including MSN, Today, and CBS News, as well as in clinical publications such as ScienceDirect. “Surpassing one million views and 14 million impressions is a milestone that reflects how far the NETHERTON NOW campaign has come,” said Denise Carter, COO. “What began as an idea to raise awareness has become a global platform that brings the harsh realities of living with Netherton Syndrome into the spotlight. We are honored to share the voices of international advocates, patients, families, and clinical experts. Together, these stories are changing how the world understands this devastating disease, building momentum within both the treatment community and the general public, and further reinforce our determination to deliver the first approved treatment.”